Cargando…

Application of Convergent Science and Technology toward Ocular Disease Treatment

Eyes are one of the main critical organs of the body that provide our brain with the most information about the surrounding environment. Disturbance in the activity of this informational organ, resulting from different ocular diseases, could affect the quality of life, so finding appropriate methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Bal-Öztürk, Ayça, Özcan-Bülbül, Ece, Gültekin, Hazal Ezgi, Cecen, Berivan, Demir, Ebru, Zarepour, Atefeh, Cetinel, Sibel, Zarrabi, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053244/
https://www.ncbi.nlm.nih.gov/pubmed/36986546
http://dx.doi.org/10.3390/ph16030445
_version_ 1785015367351926784
author Bal-Öztürk, Ayça
Özcan-Bülbül, Ece
Gültekin, Hazal Ezgi
Cecen, Berivan
Demir, Ebru
Zarepour, Atefeh
Cetinel, Sibel
Zarrabi, Ali
author_facet Bal-Öztürk, Ayça
Özcan-Bülbül, Ece
Gültekin, Hazal Ezgi
Cecen, Berivan
Demir, Ebru
Zarepour, Atefeh
Cetinel, Sibel
Zarrabi, Ali
author_sort Bal-Öztürk, Ayça
collection PubMed
description Eyes are one of the main critical organs of the body that provide our brain with the most information about the surrounding environment. Disturbance in the activity of this informational organ, resulting from different ocular diseases, could affect the quality of life, so finding appropriate methods for treating ocular disease has attracted lots of attention. This is especially due to the ineffectiveness of the conventional therapeutic method to deliver drugs into the interior parts of the eye, and the also presence of barriers such as tear film, blood-ocular, and blood-retina barriers. Recently, some novel techniques, such as different types of contact lenses, micro and nanoneedles and in situ gels, have been introduced which can overcome the previously mentioned barriers. These novel techniques could enhance the bioavailability of therapeutic components inside the eyes, deliver them to the posterior side of the eyes, release them in a controlled manner, and reduce the side effects of previous methods (such as eye drops). Accordingly, this review paper aims to summarize some of the evidence on the effectiveness of these new techniques for treating ocular disease, their preclinical and clinical progression, current limitations, and future perspectives.
format Online
Article
Text
id pubmed-10053244
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100532442023-03-30 Application of Convergent Science and Technology toward Ocular Disease Treatment Bal-Öztürk, Ayça Özcan-Bülbül, Ece Gültekin, Hazal Ezgi Cecen, Berivan Demir, Ebru Zarepour, Atefeh Cetinel, Sibel Zarrabi, Ali Pharmaceuticals (Basel) Review Eyes are one of the main critical organs of the body that provide our brain with the most information about the surrounding environment. Disturbance in the activity of this informational organ, resulting from different ocular diseases, could affect the quality of life, so finding appropriate methods for treating ocular disease has attracted lots of attention. This is especially due to the ineffectiveness of the conventional therapeutic method to deliver drugs into the interior parts of the eye, and the also presence of barriers such as tear film, blood-ocular, and blood-retina barriers. Recently, some novel techniques, such as different types of contact lenses, micro and nanoneedles and in situ gels, have been introduced which can overcome the previously mentioned barriers. These novel techniques could enhance the bioavailability of therapeutic components inside the eyes, deliver them to the posterior side of the eyes, release them in a controlled manner, and reduce the side effects of previous methods (such as eye drops). Accordingly, this review paper aims to summarize some of the evidence on the effectiveness of these new techniques for treating ocular disease, their preclinical and clinical progression, current limitations, and future perspectives. MDPI 2023-03-16 /pmc/articles/PMC10053244/ /pubmed/36986546 http://dx.doi.org/10.3390/ph16030445 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Bal-Öztürk, Ayça
Özcan-Bülbül, Ece
Gültekin, Hazal Ezgi
Cecen, Berivan
Demir, Ebru
Zarepour, Atefeh
Cetinel, Sibel
Zarrabi, Ali
Application of Convergent Science and Technology toward Ocular Disease Treatment
title Application of Convergent Science and Technology toward Ocular Disease Treatment
title_full Application of Convergent Science and Technology toward Ocular Disease Treatment
title_fullStr Application of Convergent Science and Technology toward Ocular Disease Treatment
title_full_unstemmed Application of Convergent Science and Technology toward Ocular Disease Treatment
title_short Application of Convergent Science and Technology toward Ocular Disease Treatment
title_sort application of convergent science and technology toward ocular disease treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053244/
https://www.ncbi.nlm.nih.gov/pubmed/36986546
http://dx.doi.org/10.3390/ph16030445
work_keys_str_mv AT balozturkayca applicationofconvergentscienceandtechnologytowardoculardiseasetreatment
AT ozcanbulbulece applicationofconvergentscienceandtechnologytowardoculardiseasetreatment
AT gultekinhazalezgi applicationofconvergentscienceandtechnologytowardoculardiseasetreatment
AT cecenberivan applicationofconvergentscienceandtechnologytowardoculardiseasetreatment
AT demirebru applicationofconvergentscienceandtechnologytowardoculardiseasetreatment
AT zarepouratefeh applicationofconvergentscienceandtechnologytowardoculardiseasetreatment
AT cetinelsibel applicationofconvergentscienceandtechnologytowardoculardiseasetreatment
AT zarrabiali applicationofconvergentscienceandtechnologytowardoculardiseasetreatment